Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.
about
Comparisons of pharmacokinetics and NO-releasing of nitrofibriate and fenofibrate after oral administration in rats.Prostanoids and NSAIDs in cardiovascular biology and disease.COX inhibitors: a patent review (2011 - 2014).The latest advances in the discovery of nitric oxide hybrid drug compounds.A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis
P2860
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@en
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@nl
type
label
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@en
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@nl
prefLabel
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@en
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@nl
P2093
P50
P1476
Enhancing the pharmacodynamic ...... nhibiting nitric oxide donors.
@en
P2093
Angela Di Capua
Antonietta Rossi
Antonio Giordani
Maurizio Anzini
Milena Colovic
Paola Patrignani
Salvatore Alfonso
Stefano Persiani
P304
P356
10.1016/J.BMC.2013.12.008
P407
P50
P577
2013-12-18T00:00:00Z